Invuity, Inc. (IVTY) Analysts See $-0.50 EPS

January 13, 2018 - By Kurt Siggers

 Invuity, Inc. (IVTY) Analysts See $ 0.50 EPS

Analysts expect Invuity, Inc. (NASDAQ:IVTY) to report $-0.50 EPS on February, 13.They anticipate $0.06 EPS change or 10.71 % from last quarter’s $-0.56 EPS. After having $-0.52 EPS previously, Invuity, Inc.’s analysts see -3.85 % EPS growth. The stock decreased 1.75% or $0.1 during the last trading session, reaching $5.6. About 64,073 shares traded. Invuity, Inc. (NASDAQ:IVTY) has risen 50.92% since January 13, 2017 and is uptrending. It has outperformed by 34.22% the S&P500.

Invuity, Inc. (NASDAQ:IVTY) Ratings Coverage

Among 4 analysts covering Invuity Inc (NASDAQ:IVTY), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Invuity Inc had 7 analyst reports since August 29, 2016 according to SRatingsIntel. Northland Capital maintained the shares of IVTY in report on Tuesday, June 13 with “Buy” rating. The stock of Invuity, Inc. (NASDAQ:IVTY) earned “Buy” rating by Piper Jaffray on Tuesday, July 25. Lake Street initiated Invuity, Inc. (NASDAQ:IVTY) on Monday, September 19 with “Buy” rating. The stock has “Buy” rating by Craig Hallum on Monday, August 29. The stock has “Buy” rating by Northland Capital on Wednesday, July 26.

Invuity, Inc., a medical technology company, develops various surgical devices to address various surgical procedures in the United States. The company has market cap of $95.98 million. The firm integrates its intelligent photonics technology platform into its single-use and reusable advanced surgical devices to address various critical intracavity illumination and visualization challenges. It currently has negative earnings. It offers various illuminated surgical devices, including Eikon LT Illuminated and Eikon illuminated retractor systems for breast oncology/oncoplastic/general/orthopedics surgeries; Saber Yankauer, a handheld illuminator for orthopedic/spine/cardiothoracic/breast/general surgeries; and Saber Frazier, a handheld illuminator for spine/orthopedic/neurosurgery surgeries.

More notable recent Invuity, Inc. (NASDAQ:IVTY) news were published by: which released: “Invuity Inc. Showcased PhotonBlade at Premier Inc.’s Annual Breakthroughs …” on July 12, 2017, also with their article: “Invuity Appoints Scott Flora to Board of Directors” published on November 21, 2017, published: “Invuity Announces Full Commercial Launch of PhotonBladeâ„¢” on September 25, 2017. More interesting news about Invuity, Inc. (NASDAQ:IVTY) were released by: and their article: “Invuity to Present at Piper Jaffray Healthcare Conference” published on November 21, 2017 as well as‘s news article titled: “Invuity Strengthens Senior Management With Appointment of Chief Human …” with publication date: October 17, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.